Mesa Laboratories, Inc. (MLAB) EPS Estimated At $1.93 on June, 6

May 17, 2018 - By Mark Babin

Mesa Laboratories, Inc. (NASDAQ:MLAB) Corporate Logo
Big Money Sentiment decreased to 1.21 in 2017 Q4. It has change of 0.67, from 2017Q3’s 1.88. The ratio dropped due to Mesa Laboratories, Inc. positioning: 12 sold and 26 reduced. 9 funds bought stakes and 37 increased stakes. Investors holded 2.49 million in 2017Q3 but now own 2.66 million shares or 6.81% more.
Bahl Gaynor has 12,445 shs for 0.02% of their capital. Ameriprise Fincl holds 0% or 42,923 shs. Ny State Common Retirement Fund has 0% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB). California Employees Retirement System reported 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). 3,934 are held by Parametric Port Associate Ltd Co. Keybank National Association Oh invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Wells Fargo And Communication Mn has 5,902 shs for 0% of their capital. Credit Suisse Ag owns 0% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 3,012 shs. Renaissance Technologies Lc stated it has 0.01% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Blackrock owns 0% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 175,718 shs. Northern Corporation reported 45,218 shs. Deutsche Retail Bank Ag accumulated 7,140 shs. Crawford Counsel has 0.11% invested in Mesa Laboratories, Inc. (NASDAQ:MLAB). Bank & Trust Of Montreal Can holds 17 shs or 0% of its capital. Dimensional Fund Advisors Limited Partnership, a Texas-based fund reported 134,152 shs.

Mesa Laboratories, Inc. had 2 selling transactions and 0 buys since February 15, 2018. This’s net activity of $1.27 million. $552,000 worth of Mesa Laboratories, Inc. (NASDAQ:MLAB) shs were sold by Sullivan John James.

On June, 6 WallStreet expected Mesa Laboratories, Inc. (NASDAQ:MLAB)’s earnings release, as reported by Faxor. Analysts predict $1.93 earnings per share. That’s $0.69 up or 55.65 % from 2017’s earnings of $1.24. The profit will be $7.30 million for MLAB if $1.93 earnings per share becomes true. Last quarter $-0.24 earnings per share was reported. Analysts forecasts -904.17 % EPS growth this quarter. The stock decreased 0.97% or $1.67 during the last trading session, reaching $169.8.Mesa Laboratories, Inc. has volume of 9,754 shares. Since May 17, 2017 MLAB has risen 13.08% and is uptrending. MLAB outperformed the S&P 500 by 1.53%.

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products.The firm is valued at $642.38 million. The company??s Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.Currently it has negative earnings. This segment??s products are used in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling, and semiconductor industries.

Mesa Laboratories, Inc. (NASDAQ:MLAB) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: